Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perineural Botox for chronic cutaneous neuropathic pain
2023-507259-31-00Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Oct 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Neuralgia and neuropathy comparing BOTOX with Placebo saline (2 arms). Primary endpoint: Responder rate at 4 weeks. Started Oct 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Neuralgianeuropathy
Beyond the preview
Go deeper on 2023-507259-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507259-31-00.